Rothschild Investment LLC’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24K | Buy |
110
+20
| +22% | +$407 | ﹤0.01% | 1994 |
|
|
2025
Q1 | $1.63K | Sell |
90
-15
| -14% | -$272 | ﹤0.01% | 2025 |
|
|
2024
Q4 | $2.65K | Buy |
105
+45
| +75% | +$1.14K | ﹤0.01% | 1636 |
|
|
2024
Q3 | $2.04K | Buy |
60
+35
| +140% | +$1.19K | ﹤0.01% | 1716 |
|
|
2024
Q2 | $925 | Buy |
25
+20
| +400% | +$740 | ﹤0.01% | 1701 |
|
|
2024
Q1 | $210 | Buy |
+5
| New | +$210 | ﹤0.01% | 1725 |
|